LONG QT SYNDROME PATIENTS WITH MUTATIONS OF THE SCN5A AND HERG GENES HAVE DIFFERENTIAL RESPONSES TO NA-RATE - IMPLICATIONS FOR GENE-SPECIFIC THERAPY( CHANNEL BLOCKADE AND TO INCREASES IN HEART)
Pj. Schwartz et al., LONG QT SYNDROME PATIENTS WITH MUTATIONS OF THE SCN5A AND HERG GENES HAVE DIFFERENTIAL RESPONSES TO NA-RATE - IMPLICATIONS FOR GENE-SPECIFIC THERAPY( CHANNEL BLOCKADE AND TO INCREASES IN HEART), Circulation, 92(12), 1995, pp. 3381-3386
Background The genes for the long QT syndrome (LQTS) linked to chromos
omes 3 (LQT3) and 7 (LQT2) were identified as SCN5A, the cardiac Na+ c
hannel gene, and as HERG, a K+ channel gene. These findings opened the
possibility of attempting gene-specific control of ventricular repola
rization. We tested the hypothesis that the QT interval would shorten
more in LQTS than in LQT2 patients in response to mexiletine and also
in response to increases in heart rate. Methods and Results Fifteen LQ
TS patients were studied. Six LQT3 and 7 LQT2 patients were treated wi
th mexiletine, and its effects on QT and QT(c) were measured. Mexileti
ne significantly shortened the QT interval among LQTS patients (QT(c)
from 535+/-32 to 445+/-31 ms, P<.005) but not among LQT2 patients (QT(
c) from 530+/-79 to 503+/-60 ms, P=NS). LQT3 patients (n=7) shortened
their QT interval in response to increases in heart rate much more tha
n LQT2 patients (n=4) and also more than 18 healthy control subjects (
9.45+/-3.3 versus 3.95+/-1.97 and 2.83+/-1.33, P<.05; data expressed a
s percent reduction in QT per 100-ms shortening in RR). Among these pa
tients, there is also a trend for LQT2 patients to have syncope or car
diac arrest under emotional or physical stress and for LQT3 patients t
o have cardiac events either at rest or during sleep. Conclusions This
is the first study to demonstrate differential responses of LQTS pati
ents to interventions targeted to their specific genetic defect. These
findings also suggest that LQT3 patients may be more likely to benefi
t from Na+ channel blockers and from cardiac pacing because they would
be at higher risk of arrhythmia at slow heart rates. Conversely, LQT2
patients may be at higher risk to develop syncope under stressful con
ditions because of the combined arrhythmogenic effect of catecholamine
s with the insufficient adaptation of their QT interval when heart rat
e increases.